The effect of physical barriers and properties on the oral absorption of particulates.
暂无分享,去创建一个
[1] R. Irvin,et al. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. , 1992, The Journal of clinical investigation.
[2] M. Steinhoff,et al. Potential of polymer microencapsulation technology for vaccine innovation. , 1994, Vaccine.
[3] L. Illum,et al. In vivo evaluation of protein adsorption to sterically stabilised colloidal carriers. , 1993, Journal of biomedical materials research.
[4] M. Skurnik,et al. Interactions between Yersinia enterocolitica and rabbit ileal mucus: growth, adhesion, penetration, and subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles , 1991, Infection and immunity.
[5] J. Kreuter. Nanoparticles and nanocapsules--new dosage forms in the nanometer size range. , 1978, Pharmaceutica acta Helvetiae.
[6] G J Strous,et al. Mucin-type glycoproteins. , 1992, Critical reviews in biochemistry and molecular biology.
[7] W. Rubas,et al. Mechanism of dextran transport across rabbit intestinal tissue and a human colon cell-line (CACO-2). , 1995, Journal of drug targeting.
[8] R. Crowther,et al. Counter‐ion binding to mucus glycoproteins , 1984, The Journal of pharmacy and pharmacology.
[9] D. Winne,et al. Diffusion coefficient in native mucus gel of rat small intestine , 1990, The Journal of pharmacy and pharmacology.
[10] L. Lichtenberger. The hydrophobic barrier properties of gastrointestinal mucus. , 1995, Annual review of physiology.
[11] M. Smith,et al. Particle uptake and translocation across epithelial membranes. , 1996, Journal of anatomy.
[12] M. Aprahamian,et al. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine , 1987, Biology of the cell.
[13] T. Atkins,et al. The incorporation and release of bovine serum albumin from poly(beta-hydroxybutyrate-hydroxyvalerate) microspheres. , 1996, Journal of biomaterials science. Polymer edition.
[14] E. Grulke,et al. Glass Transition Temperatures of Polymers , 1999 .
[15] P. Vadgama,et al. Electrochemical determination of the permeability of porcine mucus to model solute compounds , 1991, The Journal of pharmacy and pharmacology.
[16] M C Davies,et al. Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro. , 1991, Biomaterials.
[17] R. Erickson,et al. Is the small intestinal epithelium truly "tight" to inulin permeation? , 1991, The American journal of physiology.
[18] B. Hirst,et al. Targeting to intestinal M cells. , 1996, Journal of anatomy.
[19] J. Benoit,et al. Intestinal absorption of PLAGA microspheres in the rat. , 1996, Journal of anatomy.
[20] C. Migliaresi,et al. A study on the in vitro degradation of poly(lactic acid). , 1994, Journal of biomaterials science. Polymer edition.
[21] P. Vadgama,et al. Estimation of effective diffusion coefficients of model solutes through gastric mucus: assessment of a diffusion chamber technique based on spectrophotometric analysis. , 1991, The Analyst.
[22] T. Landsverk,et al. Phagocytosis and transcytosis by the follicle‐associated epithelium of the ileal Peyer's patch in calves , 1988, Immunology and cell biology.
[23] Sumie Yoshioka,et al. Preparation of poly(l-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate , 1991 .
[24] A. Kondo,et al. Immunological agglutination kinetics of latex particles with physically adsorbed antigens. , 1990, JIM - Journal of Immunological Methods.
[25] K. C. Ting,et al. Microparticles of poly(dl-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery , 1997 .
[26] B. Hirst,et al. Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells. , 1993, Journal of drug targeting.
[27] S. Davis,et al. The preparation and characterization ofpoly(lactide-co-glycolide) microparticles: III. Microparticle/polymer degradation rates and the in vitro release of a model protein , 1994 .
[28] G. Ponchel,et al. Dynamic swelling behaviour of gelatin/poly(acrylic acid) bioadhesive microspheres loaded with oxprenolol. , 1997, Journal of microencapsulation.
[29] R. Langer,et al. Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres. , 1997, Biomaterials.
[30] M. Cooper,et al. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix, and Peyer's patches. An electron microscopic study. , 1973, The American journal of anatomy.
[31] Bradley S. Turner,et al. Viscous fingering of HCI through gastric mucin , 1992, Nature.
[32] M. Mantle,et al. Adhesion of Yersinia enterocolitica to purified rabbit and human intestinal mucin , 1993, Infection and immunity.
[33] S. Craig,et al. PEYER'S PATCHES: AN ENRICHED SOURCE OF PRECURSORS FOR IGA-PRODUCING IMMUNOCYTES IN THE RABBIT , 1971, The Journal of experimental medicine.
[34] N Hussain,et al. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. , 1995, Journal of drug targeting.
[35] S. Nath,et al. Quantification of protein transcytosis in the human colon carcinoma cell line CaCo‐2 , 1990, Journal of cellular physiology.
[36] K. Ling,et al. Polyethylene glycol 900 permeability of rat intestinal and colonic segments in vivo and brush border membrane vesicles in vitro. , 1989, The Journal of laboratory and clinical medicine.
[37] A T Florence,et al. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. , 1994, Journal of drug targeting.
[38] M. Mantle,et al. Binding of Yersinia enterocolitica to purified, native small intestinal mucins from rabbits and humans involves interactions with the mucin carbohydrate moiety , 1994, Infection and immunity.
[39] S. Davis,et al. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. , 1991, Biochemical and biophysical research communications.
[40] J. Lamont. Mucus: The Front Line of Intestinal Mucosal Defense , 1992, Annals of the New York Academy of Sciences.
[41] E. Morris,et al. Mucus glycoprotein gels. Role of glycoprotein polymeric structure and carbohydrate side-chains in gel-formation. , 1988, Carbohydrate research.
[42] H. Ayhan,et al. Phagocytosis of monosize polystyrene-based microspheres having different size and surface properties. , 1995, Journal of biomaterials science. Polymer edition.
[43] A. Coppola,et al. Influence of physico-chemical parameters on the release of hydrocortisone acetate from albumin microspheres , 1994 .
[44] G. Volkheimer,et al. The phenomenon of persorption. , 1968, Digestion.
[45] A. Jones,et al. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. , 1974, Gastroenterology.
[46] J. Wolf,et al. The membranous epithelial (M) cell and the mucosal immune system. , 1984, Annual review of medicine.
[47] Donald E. Chickering,et al. Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.
[48] D. Bockman,et al. Light and electron microscopy of intestinal ferritin absorption. Observations in sensitized and nonsensitized hamsters (Mesocricetus auratus) , 1966 .
[49] M. Levine,et al. Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide). , 1993, Vaccine.
[50] D. Hollander,et al. Regulation of polyethylene glycol 400 intestinal permeability by endogenous and exogenous prostanoids. Influence of non-steroidal anti-inflammatory drugs. , 1990, Gut.
[51] A. Schindler,et al. Sustained drug delivery systems. I. The permeability of poly(ϵ-caprolactone), poly(DL-lactic acid), and their copolymers , 1979 .
[52] A. Allen,et al. Gastroduodenal mucosal protection. , 1993, Physiological reviews.
[53] A. Florence,et al. Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency , 1990, The Journal of pharmacy and pharmacology.
[54] J. Madara,et al. Loosening tight junctions. Lessons from the intestine. , 1989, The Journal of clinical investigation.
[55] J. Mcghee,et al. Oral Vaccine Models: Multiple Delivery Systems Employing Tetanus Toxoid a , 1994 .
[56] J. Eldridge,et al. Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. , 1989, Advances in experimental medicine and biology.
[57] S. Davis,et al. Targeting of colloidal particles to the bone marrow. , 1987, Life sciences.
[58] R. Kinne,et al. In vitro permeability of PBCA nanoparticles through porcine small intestine. , 1993, Journal of drug targeting.
[59] D. Lewis,et al. The transport of microspheres from the gastro‐intestinal tract to inflammatory air pouches in the rat , 1989, The Journal of pharmacy and pharmacology.
[60] H. Cottier,et al. Uptake by enterocytes and subsequent translocation to internal organs, eg, the thymus, of Percoll microspheres administered per os to suckling mice. , 1983, Journal of the Reticuloendothelial Society.
[61] J. Mcghee,et al. Biodegradable microspheres as a vaccine delivery system. , 1991, Molecular immunology.
[62] D. Keljo,et al. Quantitative determination of macromolecular transport rate across intestinal Peyer's patches. , 1983, The American journal of physiology.
[63] Zhaohui Li,et al. Wicking Technique for Determination of Pore Size in Ceramic Materials , 1994 .
[64] S. Kerss,et al. A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents. , 1982, Clinical science.
[65] A. Florence,et al. Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate , 1995 .
[66] Thomas R. Tice,et al. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .
[67] D. Hollander,et al. Crohn's disease--a permeability disorder of the tight junction? , 1988, Gut.
[68] And,et al. Characteristics of binding of Escherichia coli serotype O157:H7 strain CL-49 to purified intestinal mucin , 1990, Infection and immunity.
[69] L. Balant,et al. Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles. , 1994, Journal of biomedical materials research.
[70] T. Gray,et al. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes , 1994, FEBS letters.
[71] T. Ma,et al. PEG 400, a hydrophilic molecular probe for measuring intestinal permeability. , 1990, Gastroenterology.
[72] A. Florence,et al. The effect of adsorbed poloxamer 188 and 407 surfactants on the intestinal uptake of 60-nm polystyrene particles after oral administration in the rat , 1996 .
[73] L. Illum,et al. Influence of block copolymers on the adsorption of plasma proteins to microspheres. , 1993, Biomaterials.
[74] T. Arita,et al. Interaction of tertiary amines and quaternary ammonium compounds with gastrointestinal mucin. , 1986, Journal of pharmacobio-dynamics.
[75] Nicholas A. Peppas,et al. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .
[76] S. Davis,et al. Polymeric microspheres as drug carriers. , 1988, Biomaterials.
[77] J. Kreuter. Nanoparticles and microparticles for drug and vaccine delivery. , 1996, Journal of anatomy.
[78] Z. Policova,et al. Bacterial cell surface hydrophobicity properties in the mediation of in vitro adhesion by the rabbit enteric pathogen Escherichia coli strain RDEC-1. , 1989, The Journal of clinical investigation.
[79] P. Artursson,et al. Diffusion of drugs in native and purified gastrointestinal mucus. , 1997, Journal of pharmaceutical sciences.
[80] E. Boedeker,et al. Preclinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli. , 1993, Vaccine.
[81] Eldridge,et al. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies , 1991, Infection and immunity.
[82] C. McGuinness,et al. Early intestinal microparticle uptake in the rat. , 1996, Journal of anatomy.
[83] M. Marsh,et al. Endocytosis: what goes in and how? , 1992, Journal of cell science.
[84] Y Ikada,et al. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. , 1988, Biomaterials.
[85] Nicholas A. Peppas,et al. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .
[86] Patrick J. Sinko,et al. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin , 1997 .
[87] Y. Ikada,et al. Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. , 1988, Journal of biomedical materials research.
[88] T. Ma,et al. Mechanisms of polyethylene glycol 400 permeability of perfused rat intestine. , 1989, Gastroenterology.
[89] R. Compans,et al. Oral immunization with influenza virus in biodegradable microspheres. , 1993, The Journal of infectious diseases.
[90] J. Bienenstock,et al. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. , 1979, Journal of immunology.
[91] D. McCarthy,et al. Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose , 1992 .
[92] K. Carr,et al. Gastrointestinal uptake and translocation of microparticles in the streptozotocin-diabetic rat. , 1996, Journal of anatomy.
[93] M. Deierkauf,et al. Effects of albumin on the phagocytosis of polysterene spherules by rabbit polymorphonuclear leucocytes , 1978, Journal of cellular physiology.
[94] P. Artursson,et al. Microparticles as potentially orally active immunological adjuvants. , 1989, Vaccine.
[95] R. Müller,et al. Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. , 1987, Biomaterials.
[96] E. Morris,et al. Mechanical characterization and properties of gastrointestinal mucus gel. , 1987, Biorheology.
[97] A. Dayan,et al. Translocation of particulates across the gut wall--a quantitative approach. , 1995, Journal of drug targeting.
[98] O'Hagan Dt,et al. THE INTESTINAL UPTAKE OF PARTICLES AND THE IMPLICATIONS FOR DRUG AND ANTIGEN DELIVERY , 1996 .